UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
ý
QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended: February
28, 2015
OR
¨
TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission file number: 000-04465
| PERVASIP CORP. |
| (Exact name of registrant as specified in its charter) |
| New York |
|
13-2511270 |
| (State or other jurisdiction of incorporation or organization) |
|
(I.R.S. Employer Identification No.) |
|
430 North Street
White Plains, New York 10605 |
| (Address of principal executive offices) |
| (914) 750-9339 |
| (Registrant’s telephone number, including area code) |
Indicate by check whether the registrant (1)
filed all reports required to be filed by Section 13 or 15(d) of the Securities and Exchange Act of 1934 during the preceding 12
months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
Yes ý
No ¨
Indicate by check mark whether the registrant
has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted
and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter
period that the registrant was required to submit and post such files). Yes ý
No ¨
Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.
| Large accelerated filer ☐ |
Accelerated filer ☐ |
Non-accelerated filer ☐ |
Smaller reporting company ý |
Indicate by check mark whether the registrant
is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No ý
As of June 8, 2015, the Company had 4,702,630,209 shares of its
common stock, par value $0.00001 per share, issued and outstanding.
TABLE OF CONTENTS
| |
Page |
| PART I—FINANCIAL INFORMATION |
| |
|
| Item 1. Financial Statements |
3 |
| |
|
| Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations |
19 |
| |
|
| Item 3. Quantitative and Qualitative disclosures about Market Risk |
22 |
| |
|
| Item 4. Controls and Procedures |
22 |
| |
|
| PART II—OTHER INFORMATION |
| |
|
| Item 1. Legal Proceedings |
23 |
| |
|
| Item1A. Risk Factors |
23 |
| |
|
| Item 2. Unregistered Sales of Equity Securities and Use of Proceeds |
23 |
| |
|
| Item 3. Defaults Upon Senior Securities |
23 |
| |
|
| Item 4. Mine Safety Disclosures |
23 |
| |
|
| Item 5. Other Information |
23 |
| |
|
| Item 6. Exhibits |
23 |
| |
|
| Signatures |
24 |
2
Item 1. Financial Statements.
Pervasip Corp. and Subsidiaries
Condensed Consolidated Balance Sheets
| |
(Unaudited) | |
|
| |
February 28, 2015 | |
November 30, 2014 |
| |
| |
|
| ASSETS |
| |
|
| |
| |
|
| Current assets: |
| | | |
| | |
| Cash and cash equivalents |
$ | 2,623 | | |
$ | 1,832 | |
| Marketable securities |
| 216,000 | | |
| 1,040,000 | |
| Prepaid expenses and other current assets |
| 1,165 | | |
| 3,337 | |
| Total current assets |
| 219,788 | | |
| 1,045,169 | |
| |
| | | |
| | |
| Other assets |
| 5,151 | | |
| 7,119 | |
| Total assets |
$ | 224,939 | | |
$ | 1,052,288 | |
| |
| | | |
| | |
| LIABILITIES AND STOCKHOLDERS’ DEFICIT |
| | | |
| | |
| |
| | | |
| | |
| Current liabilities: |
| | | |
| | |
| Current portion of long-term debt, net of discounts of $46,835 and $189,270 at February 28, 2015 and November 30, 2014, respectively |
$ | 4,242,109 | | |
$ | 4,631,122 | |
| Accounts payable and other accrued liabilities |
| 1,958,964 | | |
| 1,966,224 | |
| Accounts payable and other accrued liabilities – related party |
| 331,516 | | |
| 410,333 | |
| Due to Pension Benefit Guaranty Corporation |
| 2,026,768 | | |
| 2,001,984 | |
| Related party debt |
| 847,827 | | |
| 804,078 | |
| Derivative liabilities |
| 2,770,117 | | |
| 639,339 | |
| Total current liabilities |
| 12,177,301 | | |
| 10,453,080 | |
| |
| | | |
| | |
| Total liabilities |
| 12,177,301 | | |
| 10,453,080 | |
| |
| | | |
| | |
| Stockholders’ deficit: |
| | | |
| | |
| Preferred stock, $0.00001 par value; 1,000,000 shares authorized |
| | | |
| | |
| Series D: 51 shares issued and outstanding, respectively |
| — | | |
| — | |
| Convertible preferred stock, $0.00001 par value; 20,000,010 authorized |
| | | |
| | |
| Series E: 10 and 0 shares issued and outstanding, respectively |
| — | | |
| — | |
| Series F: 10,000,000 and 0 shares issued and outstanding, respectively |
| 100 | | |
| — | |
| Series G: 10,000,000 and 0 shares issued and outstanding, respectively |
| 100 | | |
| — | |
| Common stock, $0.00001 par value; 8,978,999,990 shares |
| | | |
| | |
| authorized, 2,404,058,781 and 1,194,549,997 shares issued and |
| | | |
| | |
| outstanding in 2015 and 2014, respectively |
| 24,041 | | |
| 11,945 | |
| Capital in excess of par value |
| 41,964,487 | | |
| 41,750,912 | |
| Accumulated deficit |
| (53,718,273 | ) | |
| (51,764,832 | ) |
| Accumulated other comprehensive income (loss) |
| (222,817 | ) | |
| 601,183 | |
| Total stockholders’ deficit |
| (11,952,362 | ) | |
| (9,400,792 | ) |
| Total liabilities and stockholders’ deficit |
$ | 224,939 | | |
$ | 1,052,288 | |
See accompanying notes to the unaudited
condensed consolidated financial statements.
3
Pervasip Corp. and Subsidiaries
Condensed Consolidated Statements of
Operations
(Unaudited)
| | |
For the Three Months Ended |
| | |
February 28, 2015 | |
February 28, 2014 |
| | |
| |
(Restated) |
| | |
| |
|
| Revenues | |
$ | 894 | | |
$ | 213,662 | |
| | |
| | | |
| | |
| Costs and expenses: | |
| | | |
| | |
| Cost of services | |
| 626 | | |
| 124,034 | |
| Selling, general and administrative | |
| 67,318 | | |
| 359,566 | |
| Total costs and expenses | |
| 67,944 | | |
| 483,600 | |
| | |
| | | |
| | |
| Loss from operations | |
| (67,050 | ) | |
| (269,938 | ) |
| | |
| | | |
| | |
| Other income (expense): | |
| | | |
| | |
| Interest expense | |
| (354,767 | ) | |
| (518,851 | ) |
| Amortization of deferred finance costs | |
| (5,305 | ) | |
| (17,859 | ) |
| Gain on troubled debt restructuring | |
| 527,469 | | |
| — | |
| Gain on sale of subsidiary | |
| — | | |
| 640,180 | |
| Gain on settlement of derivative liabilities | |
| 115,953 | | |
| 300,686 | |
| Gain (loss) on change in derivative liabilities | |
| (2,169,741 | ) | |
| 253,827 | |
| Total other income (expense) | |
| (1,886,391 | ) | |
| 657,983 | |
| Net income (loss) | |
| (1,953,441 | ) | |
| 388,045 | |
| | |
| | | |
| | |
| Accretion of preferred stock dividends - beneficial conversion feature | |
| (36,541 | ) | |
| — | |
| Net income (loss) attributable to common stockholders | |
$ | (1,989,982 | ) | |
$ | 388,045 | |
| | |
| | | |
| | |
| Basic earnings (loss) per share | |
$ | (0.00 | ) | |
$ | 0.00 | |
| Diluted earnings (loss) per share | |
$ | (0.00 | ) | |
$ | 0.00 | |
| | |
| | | |
| | |
| Weighted average number of common shares outstanding: | |
| | | |
| | |
| Basic | |
| 1,666,509,278 | | |
| 884,733,330 | |
| Diluted | |
| 1,666,509,278 | | |
| 2,097,022,786 | |
See accompanying notes to the unaudited
condensed consolidated financial statements.
4
Pervasip Corp. and Subsidiaries
Condensed Consolidated Statements of
Comprehensive Income (Loss)
(Unaudited)
| | |
For the Three Months Ended |
| | |
February 28, 2015 | |
February 28, 2014 |
| | |
| |
(Restated) |
| | |
| |
|
| Net income (loss) | |
$ | (1,953,441 | ) | |
$ | 388,045 | |
| | |
| | | |
| | |
| Other Comprehensive income: | |
| | | |
| | |
| Decrease in value of restricted securities | |
| (824,000 | ) | |
| | |
| Comprehensive income (loss) | |
$ | (2,777,441 | ) | |
$ | 388,045 | |
See accompanying notes to the unaudited
condensed consolidated financial statements.
5
Pervasip Corp. and Subsidiaries
Consolidated Statements of Cash
Flows
(Unaudited)
| | |
For the Three Months Ended |
| | |
February 28, 2015 | |
February 28, 2014 |
| Operating activities: | |
| |
(Restated) |
| Net income (loss) | |
$ | (1,953,441 | ) | |
$ | 388,045 | |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | |
| | | |
| | |
| Stock-based compensation | |
| 4,000 | | |
| 7,946 | |
| Provision for bad debts | |
| — | | |
| (1,107 | ) |
| Amortization of debt discount | |
| 217,425 | | |
| 373,225 | |
| Amortization of financing costs | |
| 5,305 | | |
| 17,859 | |
| Gain on troubled debt restructuring | |
| (527,469 | ) | |
| — | |
| Gain on sale of subsidiary | |
| — | | |
| (640,180 | ) |
| Gain on settlement of derivative liabilities | |
| (115,953 | ) | |
| (300,686 | ) |
| Change in fair value of derivative liabilities | |
| 2,169,741 | | |
| (253,827 | ) |
| Changes in operating assets and liabilities: | |
| | | |
| | |
| Accounts receivable | |
| — | | |
| 540 | |
| Prepaid expenses and other current assets | |
| 2,172 | | |
| 5,970 | |
| Other assets | |
| (3,337 | ) | |
| (34,126 | ) |
| Accounts payable and accrued liabilities | |
| 67,632 | | |
| 188,776 | |
| Accounts payable and accrued liabilities – related party | |
| 84,932 | | |
| 55,881 | |
| Due to Pension Benefit Guaranty Corporation | |
| 24,784 | | |
| 23,635 | |
| Net cash used in operating activities | |
| (24,209 | ) | |
| (168,049 | ) |
| | |
| | | |
| | |
| Cash flows from financing activities: | |
| | | |
| | |
| Proceeds from borrowings | |
| 25,000 | | |
| 222,500 | |
| Principal payments of debt | |
| — | | |
| (60,368 | ) |
| Net cash provided by financing activities | |
| 25,000 | | |
| 162,132 | |
| | |
| | | |
| | |
| Increase / (decrease) in cash and cash equivalents | |
| 791 | | |
| (5,917 | ) |
| Cash and cash equivalents at beginning of period | |
| 1,832 | | |
| 17,242 | |
| Cash and cash equivalents at the end of period | |
$ | 2,623 | | |
$ | 11,325 | |
| Supplemental disclosure of cash flow information: | |
| | | |
| | |
| Cash paid during the period for: | |
| | | |
| | |
| Income taxes | |
$ | — | | |
$ | — | |
| Interest | |
$ | — | | |
$ | 34,493 | |
| Non-cash financing transactions: | |
| | | |
| | |
| Fair value of derivative liabilities to discount on debt | |
$ | 74,990 | | |
$ | 230,837 | |
| Settlement of accrued interest with issuance of preferred stock | |
$ | 100,000 | | |
$ | — | |
| Settlement of payables with issuance of warrants | |
$ | 20,000 | | |
$ | — | |
| Conversion of accrued liabilities to notes payable | |
$ | 118,641 | | |
$ | 73,934 | |
See accompanying notes to the unaudited
condensed consolidated financial statements.
6
PERVASIP CORP.
Notes To Condensed Consolidated Financial
Statements
Unaudited
Note 1– Basis of Presentation
The accompanying unaudited condensed
consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim
financial information and in accordance with the rules and regulations of the U.S. Securities and Exchange Commission for
quarterly reports on Form 10-Q. Accordingly, they do not include all of the information and footnotes required by generally
accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting
of normal recurring accruals) considered necessary for a fair presentation have been included. The condensed balance sheet at
November 30, 2014 was derived from audited financial statements but does not include all disclosures required by accounting
principles generally accepted in the United States of America. Operating results for the three-month period ended February
28, 2015, are not necessarily indicative of the results that may be expected for the year ended November 30, 2015. For
further information, refer to the consolidated financial statements and notes thereto included in our Annual Report on Form
10-K for the year ended November 30, 2014.
For a summary of significant accounting policies
(which have not changed from November 30, 2014), see the Company’s Annual Report on Form 10-K for the year ended November
30, 2014.
Marketable securities
The Company classifies investments in equity
securities bought and held primarily to be sold in the short term that have readily determinable fair values, as trading securities.
Unrealized holding gains and losses for trading securities are included in earnings. Any unrealized holding gains and losses from
available-for-sale securities are excluded from earnings and are recorded in comprehensive income until a gain or loss has been
realized.
Note 2 – Going Concern Matters and
Realization of Assets
The accompanying financial statements have
been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the
ordinary course of business. However, the Company has sustained substantial losses from its operations in recent years and as of
February 28, 2015, the Company has negative working capital of $11,957,513 and a stockholders’ deficit of $11,952,362. In
addition, the Company is unable to meet its obligations as they become due and sustain its operations. The Company believes that
its existing cash resources are not sufficient to fund its continuing operating losses, debt payments and working capital requirements.
The Company may not be able to raise sufficient
additional debt, equity or other cash on acceptable terms, if at all. Failure to generate sufficient revenues, achieve certain
other business plan objectives or raise additional funds could have a material adverse effect on the Company’s results of
operations, cash flows and financial position, including its ability to continue as a going concern, and may require it to significantly
reduce, reorganize, discontinue or shut down its operations.
In view of the matters described above, recoverability
of a major portion of the recorded asset amounts shown in the accompanying balance sheet is dependent upon continued operations
of the Company which, in turn, is dependent upon the Company’s ability to meet its financing requirements on a continuing
basis, and to succeed in its future operations. The financial statements do not include any adjustments relating to
the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary
should the Company be unable to continue in its existence. Management’s plans include efforts to preserve current
revenue sources, develop new revenue sources and negotiate further debt reductions with creditors.
There can be no assurance that the Company
will be able to achieve its business plan objectives or be able to achieve or maintain cash-flow-positive operating results. If
the Company is unable to generate adequate funds from operations or raise sufficient additional funds, the Company may not be able
to repay its existing debt, continue to operate its network, respond to competitive pressures or fund its operations. As a result,
the Company may be required to significantly reduce, reorganize, discontinue or shut down its operations. The financial statements
do not include any adjustments that might result from this uncertainty.
7
Note 3 – Recent Accounting Pronouncements
and Accounting Principles
There were no recent accounting pronouncements
that have had a material effect on the Company’s financial position or results of operations.
Note 4 – Major Customers
As of February 28, 2015, all customers are
on a prepaid basis.
During the three-month periods ended February
28, 2015 and 2014, one customer accounted for 0% and 38%, respectively, of the Company’s revenues.
As of February 28, 2015 and 2014, no customer
accounted for 10% or more of the Company’s accounts receivable balance.
Note 5 – Net Income (Loss) Per Common
Share
Basic net income (loss) per share is computed
by dividing net income available to common stockholders (numerator) by the weighted average number of vested, common shares outstanding
during the period (denominator). Diluted net income (loss) per share is computed on the basis of the weighted average number of
shares of common stock outstanding plus the effect of dilutive potential common shares outstanding during the period using the
if-converted method. Dilutive potential common shares include shares issuable upon exercise of outstanding stock options, warrants
and convertible debt agreements.
| | |
Three months ended February 28, |
| | |
2015 | |
2014 |
| Net income (loss) – attributable to common stockholders
basic | |
$ | (1,989,982 | ) | |
$ | 388,045 | |
| Interest expense – convertible notes | |
| — | | |
| 76,493 | |
| Net income (loss) – attributable to common
stockholders diluted | |
$ | (1,989,982 | ) | |
$ | 464,538 | |
| | |
| | | |
| | |
| Weighted average common shares outstanding - basic | |
| 1,666,509,278 | | |
| 884,733,330 | |
| Effect of dilutive securities | |
| — | | |
| 1,212,279,456 | |
| Weighted average common shares outstanding – diluted | |
| 1,666,509,278 | | |
| 2,097,022,786 | |
| | |
| | | |
| | |
| Earnings (loss) per common share - basic | |
$ | (0.00 | ) | |
$ | 0.00 | |
| Earnings (loss) per common share - diluted | |
$ | (0.00 | ) | |
$ | 0.00 | |
Approximately 11,903,811,000 shares of
common stock issuable upon the exercise of our outstanding stock options, warrants or convertible debt were excluded from the
calculation of net income (loss) per share for the three-month period ended February 28, 2015 because the effect would be
anti-dilutive. Also excluded are shares of common stock issuable upon the conversion of our Series E, F and G preferred
stock. At February 28, 2015, Series E preferred shares could convert into approximately 9,696,235,000 shares of common stock.
Series F and G preferred shares are not convertible at February 28, 2015. Approximately 86,919,000 shares of common stock
issuable upon the exercise of our outstanding stock options, warrants or convertible debt were excluded from the calculation
of net income (loss) per share for the three-month period ended February 28, 2014 because the effect would be
anti-dilutive.
8
Note 6 – Stock-Based Compensation
Plans
The Company issues stock options to its employees,
consultants and outside directors pursuant to stockholder-approved and non-approved stock option programs and records the applicable
expense in accordance with the authoritative guidance of the Financial Accounting Standards Board. For the three-month periods
ended February 28, 2015 and 2014, the Company recorded $4,000 and $7,946, respectively, in stock-based compensation expense. As
of February 28, 2015, there no remaining unrecognized employee stock-compensation expense for previously granted unvested options.
Note 7 – Accounts Payable and Accrued
Expenses
When the
Company sold certain subsidiaries in December 2006, the Company agreed to reimburse the purchaser for certain disputed claims on
the books of the subsidiaries, if the sold subsidiaries were required to pay such claims. At February 28, 2015 and November 30,
2014, the Company has recorded a payable of $796,499 in conjunction with the sale of the subsidiaries. The subsidiary filed for
bankruptcy on September 23, 2008, which is still ongoing. If claims are reduced or eliminated by the subsidiaries, and the purchaser
provides the Company with appropriate documentation that the Company’s liability has been reduced, such reduction will be
reflected on the books of the Company.
Note 8 – Defined Benefit Plan
The Company received a letter dated July 27,
2011 from the Pension Benefit Guaranty Corporation, (“PBGC”), stating that the Company’s defined benefit pension
plan (the “Plan”) was terminated as of September 30, 2010, and the PBGC was appointed trustee of the Plan. Pursuant
to the agreement, the PBGC has a claim to the Company for the total amount of the unfunded benefit liabilities of the Plan plus
accrued interest. The PBGC has notified the Company that the liability is due and payable as of the termination date, and interest
accrues on the unpaid balance at the applicable rate provided under Section 6621(a) of the Internal Revenue Code. The total amount
outstanding to the PBGC at February 28, 2015 and November 30, 2014 was $2,026,768 and $2,001,984, respectively, including accrued
interest, which is recorded as a current liability. The Company made no payments to the Plan in the three-month periods ended February
28, 2015 and 2014. The Plan covers approximately 40 former employees.
Effective June 30, 1995, the Plan was frozen,
ceasing all benefit accruals and resulting in a plan curtailment. As a result of the curtailment, it has been the Company’s
policy to recognize the unfunded status of the Plan as of the end of the fiscal year with a corresponding charge or credit to earnings
for the change in the unfunded liability. There was no pension expense recorded in the three-month periods ended February
28, 2015 and 2014.
Effective January 14, 2015, the Company executed
a settlement and release agreement with the PBGC pursuant to which PBGC agreed to accept $100,000 in full satisfaction of all amounts
that had been due from the Company, which amounted to $2,026,768 at February 28, 2015. The Company agreed to pay the sum of $100,000
to PBGC in equal installments of $25,000 on January 31, 2015, April 30, 2015, July 31, 2015 and October 31, 2015. Upon receipt
of the settlement amount, the PBGC shall be deemed to have released the Company from any and all employer liability and fiduciary
responsibility. No installment payments have been made and the Company has not received a default notice from PBGC.
Note 9 – Debt
| | |
February 28, 2015 | |
November 30, 2014 |
| Debt due to Laurus | |
$ | 1,804,700 | | |
$ | 2,266,186 | |
| Convertible debt due to Secured Lender | |
| 1,930,000 | | |
| 1,935,190 | |
| Convertible debt due to various lenders | |
| 383,750 | | |
| 448,520 | |
| Other short-term debt due to various lenders | |
| 170,494 | | |
| 170,496 | |
| Total debt | |
| 4,288,944 | | |
| 4,820,392 | |
| Less: current portion of long-term debt | |
| (4,242,109 | ) | |
| (4,631,122 | ) |
| Less: discount on debt | |
| (46,835 | ) | |
| (189,270 | ) |
| Total long-term debt | |
$ | — | | |
$ | — | |
9
Debt
due to Laurus
As of February 28, 2015 and November 30, 2014,
the Company owed a third party lender, LV Administrative Services, Ltd., as agent for Laurus Master Fund, Ltd. and various affiliates
(“Laurus”), $1,804,700 and $2,266,186, respectively. All of such debt became due by its terms on September
28, 2010. Pursuant to two assignment agreements, in which the Company and Laurus agreed to assign the debt to a third
party, the interest rate on the debt was changed to zero percent from January 31, 2012 to April 12, 2013. Beginning on April 12,
2013, the interest rate on the Laurus debt reverted to the rate charged in the original note agreements, which ranges from 5.25%
to 20% per annum. The Company has not made payments of principal or interest when due, and is not in compliance with its agreements
with Laurus. Laurus has not issued a default notice and had signed an agreement, on two separate occasions, to sell all of its
debt at a discount to a third party, however the third parties did not fulfill all of the terms of the agreements and $1,804,700
and $2,266,186 of debt remains due to Laurus at February 28, 2015 and November 30, 2014, respectively.
On December 31, 2014, Laurus and the Company
again entered into an agreement (the “Settlement Agreement”) to assign the remaining debt to a third party for $100,000.
In the first quarter of fiscal 2015, $30,000 of the $100,000 was paid, and the Company recognized a $497,279 gain from troubled
debt restructuring on the pro-rata reduction of the debt due to Laurus. The Settlement Agreement was then assigned to EXO Opportunity
Fund, which has agreed to pay the remaining $70,000 to Laurus. Such payment would eliminate the balances due from the Company to
Laurus and release the security interest and liens filed by Laurus.
Convertible
debt due to Secured Lender
In March 2013, 112359 Factor Fund, LLC (the
“Fund”), was assigned the $6,368,078 of outstanding debt owed to Laurus, which the Fund could satisfy in full by making
certain payments to Laurus. Factor Fund did not abide by the contractual terms of the assignment agreement; therefore, at February
28, 2015 and November 30, 2014, the Company is still obligated to Laurus as noted above.
During February 2013, the Company entered into
a securities purchase agreement with the Fund pursuant to which the Company issued to the Fund (i) an amended convertible debenture
in the principal amount of $1,000,000 (“Amended Note 1”) and (ii) a second amended convertible debenture in the principal
balance of $1,000,000 (“Amended Note 2” and together with Amended Note 1, the “Amended Notes”). The
Amended Notes were sold to the Fund by the Company in exchange for the Fund’s assumption and payment of the Laurus assignment
agreement (which required the Fund to make payments totaling $350,000, of which $250,000 was paid, to Laurus), payment to the Company
of $150,000, and the agreement to purchase from another lender and cancel an existing convertible debenture in the amount of approximately
$35,000.
The Amended Notes originally matured on December
31, 2014. Amended Note 1 was modified in January 2015 to mature on December 31, 2015 and the Fund agreed that upon payment in full
of the remaining balance of Amended Note 1, that Amended Note 2 would be considered paid in full. Interest accrues on
the unpaid principal and interest on the notes at a rate per annum equal to 6% for Amended Note 1 and 2% for Amended Note 2.
Principal and interest payments on Amended
Note 1 can be made at any time by the Company, with a 30% prepayment premium, or the Fund can elect at any time to convert any
portion of Amended Note 1 into shares of common stock of the Company at 100% of the volume weighted average price of the common
stock for the 45 trading days immediately prior to the conversion date. During the three months ended February 28, 2014,
the Fund converted $273,400 of principal into 203,000,000 shares of common stock of the Company. No conversions were recorded during
the three months ended February 28, 2015.
The conversion price of Amended Note 1 is based
on a variable that is not an input to the fair value of a “fixed-for-fixed” option as defined under FASB ASC Topic
No. 815 - 40. The fair value of the note was recognized as a derivative instrument at the issuance date and was measured at fair
value at each reporting period. The Company determined that the fair value of the notes was $1,703,423 at the issuance dates. The
value of the debt of $1,000,000 was recorded as a debt discount and is amortized to interest expense over the term of the Notes.
The variance to the fair value of $703,423 was recognized as an initial loss and recorded to interest expense.
Amended Note 2 converts into shares of common
stock of the Company in an amount equal to the lesser of the outstanding balance of Amended Note 2 divided by $0.01. Any principal
or interest amount can be paid in cash.
10
During the year ended November 30, 2013, the
Fund also loaned the Company amounts of $50,000, $35,000 and $12,000 (the “Bridge Notes”). In June 2013 the Fund refinanced
the Bridge Notes with additional funding into another note for $665,000 (the “New Note”). The additional funding under
the New Note provided cash to purchase two outstanding convertible debentures for an aggregate price of $99,360; cash for operations
of $60,000 in June 2013; and $40,000 in cash each month for the months of July 2013 through December 2013. The Company incurred
$68,640 in finder fees and legal fees in connection with the New Note, and a $100,000 original issuance discount. The New Note
bears interest at 6% per annum and was due December 31, 2014. The Fund can elect at any time to convert any portion of the New
Note into shares of common stock of the Company at 60% of the volume weighted average price of the common stock for the 20 trading
days immediately prior to the conversion date. The Company received an aggregate of $300,000 in cash under the New Note in the
months of June through December 2013 under the New Note.
The conversion price of the $665,000 of variable
conversion price note is based on a variable that is not an input to the fair value of a “fixed-for-fixed” option as
defined under FASB ASC Topic No. 815 - 40. The fair value of the conversion feature was recognized as a derivative instrument at
the issuance date and is measured at fair value at each reporting period. The Company determined that the fair value of the conversion
feature was $1,103,940 at the issuance date. Debt discount was recorded up to the $625,000 face amount of the note and is amortized
to interest expense over the term of the note. The fair value of the conversion feature in excess of the principal amount allocated
to the notes in the aggregate amount of $478,940 was expensed immediately as additional interest expense
In conjunction with the New Note, the Company
agreed to implement a salary deferral plan to reduce the cash expenditures for personnel, to limit its cash expenditures to certain
pre-approved items, and to accrue an additional fee to the Fund of $150,000, which was included in interest expense and added to
the principal balance of Amended Note 1. The Fund agreed to limit its sales of the Company’s common stock, to
not engage in any short transactions involving the Company’s common stock, and to not require the Company to increase its
authorized shares of common stock for a certain time period, even though the financing documents require the Company to reserve
authorized shares for issuance to the Fund, if the Fund desired to convert existing debt into shares of common stock.
Effective January 20, 2015, the Company signed
a debt modification agreement with the Fund. The modification reduced the outstanding balance on Amended Note 1 from $280,190 to
$250,000, and provided that upon the completion of the payments required to retire Amended Note 1, the outstanding balance of Amended
Note 2 would be reduced to from $1,000,000 to $0. The Fund subsequently assigned the remaining balance of Amended Note 1 and the
related security agreements to EXO Opportunity Fund LLC (“EXO”). The Company also received $25,000 in cash in February
2015, in conjunction with a variable rate convertible debenture payable to EXO (“the EXO Note), which matures on December
31, 2015, bears interest at an annual rate of 6%, and is subject to the same security agreements as Amended Note 1.
The conversion price of the EXO Note is based
on a variable that is not an input to the fair value of a “fixed-for-fixed” option as defined under FASB ASC Topic
No. 815 - 40. The fair value of the notes was recognized as a derivative instrument at the issuance date and is measured at fair
value at each reporting period. The Company determined that the fair value of the note was $74,990 at the issuance date. Debt discount
was recorded up to the $25,000 face amount of the note and is amortized to interest expense over the term of the note. The fair
value of the conversion feature in excess of the principal amount allocated to the notes in the aggregate amount of $49,990 was
expensed immediately as additional interest expense.
On January 21, 2015, the Company signed a second
debt modification agreement with the Fund. This modification provided for the reduction of the principal balance of the New Note
from $634,600 to $250,000, subject to certain conditions precedent. The Fund assigned a $250,000 portion of the New Note and the
related security agreements to two new debt holders in equal amounts of $125,000 each. Subsequent to the balance sheet date of
February 28, 2015, the Company met the conditions precedent in the debt modification agreement, and recognized a gain of $384,600
in its second quarter of fiscal 2015.
In conjunction with the debt modification agreement
for Amended Note 1, the Company recognized a gain on troubled debt restructuring of $30,190, which combined with the gain on the
Settlement Agreement with Laurus, provided an aggregate gain on troubled debt restructuring of $527,469 for the three-month period
ended February 28, 2015.
The Amended Notes, New Note and EXO Note (the
“Secured Lenders”) are secured by a blanket lien on substantially all of the Company’s assets pursuant to the
terms of security agreements executed by the Company and its subsidiaries in favor of the Fund. In addition, the Company’s
chief executive officer pledged his voting control of the Company pursuant to a stock pledge agreement in favor of the Secured
Lenders, to further secure the Company’s obligations. If an event of default occurs under the security agreement,
the stock pledge agreement, the Amended Notes , the New Note or the EXO Note, the secured parties have the right to accelerate
payments under such promissory notes and, in addition to any other remedies available to them, to foreclose upon the assets securing
such promissory notes.
11
At February 28, 2015 and November 30, 2014,
the Company owed the Fund $1,930,000 and $1,935,190, respectively.
Convertible
Debt due to various lenders
Convertible
debt with a fixed conversion rate
At February
28, 2015 and November 30, 2014, the Company owed a lender $138,000, in connection with two notes that are past due, are in default,
bear a default interest rate of 18% per annum, and are convertible at prices of $0.015 and $0.02 cents per share.
At February
28, 2015 and November 30, 2014, the Company owed another lender $63,000 in convertible debt with a minimum conversion price of
$0.00005 per share. The lender can elect at any time to convert any portion of the debt into shares of common stock of the
Company at a discount of 49% of the price of the common stock as defined in the agreement, subject to a minimum conversion price
of $0.00005 per share. Effective March 3, 2015, the lender notified the Company it was in default and that in accordance with the
default provisions of the lending agreement, the amount of principal that the Company was required to pay back to the lender via
debt conversions, was increased to $94,500. On April 21, 2015, the lender assigned the note to EXO.
At February 28, 2015 and November 30, 2014,
a total of $201,000 of convertible debt with a fixed conversion rate was outstanding.
Convertible
debt with a variable conversion rate issued for cash
During the three months ended February 28,
2014, the Company received a total of $152,500 in cash from two lenders for convertible debt. The convertible debt bears interest
at an annual rate of 6% to 8% is due between June and October 2015. The lender can elect at any time to convert any portion of
the debt into shares of common stock of the Company, subject to a limit of 4.99% of the outstanding shares, at a price discount
ranging from 30% to 42% of the price of the common stock as defined in the agreements.
The conversion price of the $152,500 of
variable conversion price notes is based on a variable that is not an input to the fair value of a
“fixed-for-fixed” option as defined under FASB ASC Topic No. 815 - 40. The fair value of the notes was recognized
as a derivative instrument at the issuance date and is measured at fair value at each reporting period. The Company
determined that the fair value of the conversion feature was $163,714 at the issuance dates. The
debt was recorded as a debt discount of $152,102 and is amortized to interest expense over the term of the note. The
fair value of the conversion feature in excess of the principal amount allocated to the notes in the aggregate amount of
$11,612 was expensed immediately as additional interest expense.
At February 28, 2015 and November 30, 2014,
a total of $115,000 and $179,770 of variable-rate convertible debt that had been issued for cash was outstanding, respectively.
Convertible
debt with a variable conversion rate assigned to lenders
During
the three months ended February 28, 2015 and 2014, no other debt with a variable conversion
rate was assigned to a lender. At February 28, 2015 and November 30, 2014, the Company
owes one lender $67,750 as a result of an assignment in fiscal 2012. The convertible debt bears interest at 0% and is past due.
The lender can elect at any time to convert any portion of the debt into shares of common stock of the Company at a price discount
of 55% of the market price of the Company’s common stock as defined in the agreements.
At February 28, 2015 and November 30, 2014,
a total of $383,750 and $448,520 of other convertible debt was outstanding, respectively.
Other
short-term debt due to various lenders
During
the three months ended February 28, 2015 and 2014, the Company received $0 and $30,000,
respectively from lenders in exchange for notes payable that had no conversion features.
At February 28, 2015 and November
30, 2014, the Company owed various lenders approximately $170,500 for
non-convertible notes. Cash payments were made on these notes of $0 and $60,368 during the three months ended February
28, 2015 and 2014, respectively. Other short-term debt carries an interest rate
of 0% to 17% over the term of the loans, and includes cash advances (the “Cash Advances”) from lenders that
purchased future sales. The Company agreed to repay the Cash Advances at a premium to the amount received from the lender.
For the three months ended February 28, 2015 and 2014, $0 and $26,668,
respectively, of amortization of premium from the Cash Advances is included in interest expense. At February 28, 2015 and
November 30, 2014, Cash Advances totaled $67,196. Assets of a subsidiary of the Company secure the Cash Advances, which are
currently in default.
12
Note 10 - Derivative Liabilities
The Company evaluated
its convertible note agreements pursuant to ASC 815 and for those notes in which there was no minimum or fixed conversion price
resulting in an indeterminate number of shares to be issued in the future, the Company determined an embedded derivative existed
and ASC 815 applied for its convertible notes. The Company valued the embedded derivatives using the Black-Scholes valuation model.
Convertible debt with a variable conversion
feature
In 2015, the Company estimated the fair
value of the derivatives using the Black-Scholes valuation method with assumptions including: (1) term of 0 to 0.84 years; (2)
a computed volatility rate of 775%; (3) a discount rate of 1%; and (4) zero dividends. Upon settlement the valuation of this
embedded derivative was recorded as gain/loss on derivative liability.
In 2014, the Company estimated the fair
value of the derivatives using the Black-Scholes valuation method with assumptions including: (1) term of 0 to 0.84 years; (2)
a computed volatility rate of 201%; (3) a discount rate of 1%; and (4) zero dividends. Upon settlement the valuation of this
embedded derivative was recorded as gain/loss on derivative liability.
Tainted conventional convertible debt
In 2015, the Company estimated the
fair value of the derivative using the Black-Scholes valuation method with assumptions including: (1) term of .32 to .84
years; (2) a computed volatility rate of 775%; (3) a discount rate of 1%; and (4) zero dividends. The valuation of this
embedded derivative was recorded with an offsetting gain/loss on derivative liability.
In 2014, the Company estimated the fair
value of the derivative using the Black-Scholes valuation method with assumptions including: (1) term of .84 years; (2) a computed
volatility rate of 201%; (3) a discount rate of 1%; and (4) zero dividends. The valuation of this embedded derivative was
recorded with an offsetting gain/loss on derivative liability.
Tainted warrants
The Company also evaluated all outstanding
warrants to determine whether these instruments may be tainted. All warrants outstanding were considered tainted as a result of
the tainted equity environment and potential inability of the Company to settle the instruments with shares of the Company’s
stock as the number of shares issuable cannot be estimated and could exceed the amount of authorized shares available to be issued
by the Company. The Company valued the embedded derivatives within the warrants using the Black-Scholes valuation model.
In 2015, the Company estimated the
fair value of the derivative using the Black-Scholes valuation method with assumptions including: (1) term of .96 to 8.33
years; (2) a computed volatility rate of 775%; (3) a discount rate of 1%; and (4) zero dividends. The valuation of this
embedded derivative was recorded with an offsetting gain/loss on derivative liability.
In 2014, the Company estimated the
fair value of the derivative using the Black-Scholes valuation method with assumptions including: (1) term of .76 to 9.33
years; (2) a computed volatility rate of 201%; (3) a discount rate of 1%; and (4) zero dividends. The valuation of this
embedded derivative was recorded with an offsetting gain/loss on derivative liability.
Activity for embedded derivative instruments during the three months
ended February 28, 2015 was as follows:
| | |
| |
Initial valuation | |
| |
| |
|
| | |
| |
of derivative | |
| |
| |
|
| | |
| |
liabilities upon | |
Change in | |
| |
|
| | |
Balance at | |
issuance of new | |
fair value of | |
Conversion | |
Balance at |
| | |
November 30, | |
securities during | |
derivative | |
of | |
February 28, |
| | |
2014 | |
the period | |
liabilities | |
debt to equity | |
2015 |
| Variable convertible debt | |
$ | 527,781 | | |
$ | 74,990 | | |
$ | 2,049,033 | | |
$ | (115,953 | ) | |
$ | 2,535,852 | |
| Tainted convertible debt | |
| 106,246 | | |
| — | | |
| 106,082 | | |
| — | | |
| 212,328 | |
| Tainted warrants | |
| 5,312 | | |
| 2,000 | | |
| 14,625 | | |
| — | | |
| 21,937 | |
| | |
$ | 639,339 | | |
$ | 76,990 | | |
$ | 2,169,741 | | |
$ | (115,953 | ) | |
$ | 2,770,117 | |
13
Activity for embedded derivative instruments during the three months
ended February 28, 2014 was as follows:
| | |
| |
Initial valuation | |
| |
| |
|
| | |
| |
of derivative | |
| |
| |
|
| | |
| |
liabilities upon | |
Change in | |
| |
|
| | |
Balance at | |
issuance of new | |
fair value of | |
Conversion | |
Balance at |
| | |
November 30, | |
securities during | |
derivative | |
of | |
February 28, |
| | |
2013 | |
the period | |
liabilities | |
debt to equity | |
2014 |
| Variable convertible debt | |
$ | 1,467,182 | | |
$ | 230,837 | | |
$ | (117,289 | ) | |
$ | (300,920 | ) | |
$ | 1,279,810 | |
| Tainted convertible debt | |
| 139,953 | | |
| — | | |
| (121,361 | ) | |
| — | | |
| 18,592 | |
| Tainted warrants | |
| 198,035 | | |
| — | | |
| (15,177 | ) | |
| — | | |
| 50,031 | |
| | |
$ | 1,805,170 | | |
$ | 230,837 | | |
$ | (253,827 | ) | |
$ | (300,920 | ) | |
$ | 1,348,433 | |
| | |
| | | |
| | | |
| | | |
| | | |
| | |
Note 11 – Income Taxes
At February 28, 2015, the Company had net operating
loss carryforwards for federal income tax purposes of approximately $32,000,000 that expire in the years 2015 through 2034. The
Company has provided an allowance for the full value of the related deferred tax asset since it is more likely than not that none
of such benefit will be realized. Utilization of the net operating losses may be subject to annual limitations provided by Section
382 of the Internal Revenue Code and similar state provisions.
Note 12 – Stockholders’ Equity
As discussed
in Note 9, the Company entered into various transactions where it issued convertible notes to third parties. Such convertible notes
allowed the debt holders to convert outstanding debt principal into shares of the Company’s common stock at a discount to
the trading price of the common stock. To the extent, if any, that there was a beneficial conversion feature associated with these
debts, the beneficial conversion feature was bifurcated from the host instrument and accounted for as a freestanding derivative.
As a result of such conversions, in the three-month period ended February 28, 2015, $103,870 of principal and accrued interest
was converted into 1,169,508,784 shares of common stock. Also during the first quarter of 2015, the Company issued 40,000,000 shares
of common stock for services rendered, which was valued at $4,000.
On January 13, 2015, 10 shares of Series E
Preferred, 10,000,000 shares of Series F Preferred and 10,000,000 shares of Series G preferred were issued to our chief executive
officer in exchange for $100,000 in debt.
The Series E Preferred has voting rights equal
to 400% of the sum of the common stock, Series D Preferred, Series F Preferred and Series G Preferred, but no dividend rights and
no liquidation rights. The Series E Preferred is convertible into the number of common shares equal to its voting rights.
The Series F Preferred has voting rights equal
to 100 million common shares and a liquidation preference of $10,000,000 over junior securities. Each share of Series F Preferred
Stock shall be convertible at any time after their six-month anniversary date, if the Company is current with the filing of public
reports pursuant to Section 12 or 15 of the Securities Exchange Act of 1934, or after twelve months if such reports are not filed,
into the number of shares of the Corporation's common stock, equal to the price of the Series F Preferred Stock of $2.50 per share,
divided by the par value of the Series F Preferred, subject to adjustment as may be determined by the Board of Directors. Shares
of Series F Preferred Stock are anti-dilutive to reverse splits, so that in the event of a reverse split, the shares are convertible
into the same number of common shares after the reverse split as would have been issued before the reverse split. The conversion
rate of Series F Preferred Stock, however, increases proportionately in the case of forward splits, and may not be diluted by a
reverse split following a forward split.
The Series G Preferred has voting rights equal
to 10 million common shares and a liquidation preference of $10,000,000 over junior securities. Each share of Series G Preferred
Stock shall be convertible, at any time after their six-month anniversary date, if the Company is current with the filing of public
reports pursuant to Section 12 or 15 of the Securities Exchange Act of 1934, or after twelve months if such reports are not filed,
into 500 shares of the Corporation's common stock. Shares of Series G Preferred Stock are anti-dilutive to reverse splits, so that
in the event of a reverse split, the shares are convertible into the same number of common shares after the reverse split as would
have been issued before the reverse split. The conversion rate of Series G Preferred Stock, however, increases proportionately
in the case of forward splits, and may not be diluted by a reverse split following a forward split.
14
ASC 480, Distinguishing Liabilities from
Equity, sets forth the requirements for determination of whether a financial instrument contains an embedded derivative that
must be bifurcated from the host contract, therefore the Company evaluated whether the conversion feature for Series E, F and G
Preferred Stock would require such treatment; one of the exceptions to bifurcation of the embedded conversion feature is that the
conversion feature as a standalone instrument would be classified in stockholders’ equity. Management has determined that
the newly issued preferred stock is more akin to equity than debt, as the preferred stock has no redemption features and dividends
have not been provided for in the preferred stock designations.
Each share of Series F and Series G convertible
preferred stock is convertible into 250,000 and 500 shares of Common Stock, respectively, which gives the holder of the Series
F and Series G a beneficial conversion price. At the issuance date of January 13, 2015, the effective conversion price was less
than the fair value of the common stock into which the preferred shares are convertible. Consequently, the Company recognized
a beneficial conversion feature (“BCF”). The intrinsic value of the BCF is limited to the basis that is initially
allocated to the convertible security. The Company recorded a discount on the preferred stock of $100,000 from the value of the
Series F and Series G shares issued in exchange for outstanding payables to the chief executive officer (see Note 13 – Related
Party Transactions). The discount is being accreted to preferred stock dividends over a six-month period, as the preferred stock
is convertible after six months (date of earliest conversion). Accretion amounted to $36,541 for the three-month period ended
February 28, 2015.
On March 19, 2015 the Company filed a certificate
of amendment of its certificate of incorporation in which the Board of Directors designated the Series H Preferred Stock from the
Company’s previously authorized preferred stock with a par value per share of $0.00001. The number of shares of Series H
Preferred Stock was set at 800,000 shares. Shares of Series H Preferred Stock have conversion rights into shares of Common Stock.
The number of shares of Common Stock to which a holder of Series H Preferred Stock shall be entitled upon a Conversion shall equal
the product obtained by (a) multiplying the number of fully-diluted Common Shares by four (4), then (b) multiplying the result
by a fraction, the numerator of which will be the number of shares of Series H Preferred Stock being converted and the denominator
of which will be the number of authorized shares of Series H Preferred Stock. If the Company delays in issuing
shares of Common Stock beyond three trading days after the Company receives a notice of conversion from a Series H Preferred Stock
shareholder, the Company is required to pay for the losses incurred by the Series
H Preferred Stock shareholder as a result of the delay.
Each share of Series H Preferred Stock shall
entitle the holder thereof, on all matters submitted to a vote of the stockholders of the Corporation, to that number of votes
as shall be equal to the aggregate number of shares of Common Stock into which such holder's shares of Series H Preferred Stock
are convertible on the record date for the stockholder action.
In the event that the Corporation’s Board
of Directors declares a dividend payable to holders of any class of stock, the holder of each share of Series H Preferred Stock
shall be entitled to receive a dividend equal in amount and kind to that payable to the holder of the number of shares of the Company’s
Common Stock into which that holder’s Series H Preferred Stock could be converted on the record date for the dividend.
Upon the liquidation, dissolution and winding
up of the Corporation, the holders of the Series H Preferred Stock shall be entitled to receive in cash out of the net assets of
the Corporation, whether from capital or from earnings available for distribution to its stockholders, before any amount shall
be paid to the holders of common stock or to the holders of any other class or series of equity stock, an amount equal to eighty
percent (80%) of said net assets multiplied by a fraction, the numerator of which shall be the number of outstanding shares of
Series H Preferred Stock on the record date for the distribution and the denominator of which shall be the number of authorized
shares of Series H Preferred Stock.
Effective March 26, 2015, the Company issued
1,000,000,000 shares of common stock and 100,000 shares of its Series H Preferred stock to Flux Carbon Corporation, in conjunction
with the purchase of 90% of the equity of Canalytix LLC (“Canalytix”).
Note 13 – Related Party Transactions
We paid fees to a third-party intellectual property development firm (the “Consultant”) for the
three-month periods ended February 28, 2014 of $48,000. One of our former officers performed work for the Consultant, including
the function of distributing such funds to appropriate vendors, for which he was not compensated. The fees for software development
services performed by the Consultant were deemed to be operating costs.
At February 28, 2015 and November 30, 2014,
we owed our chief executive officer $1,179,343 and $1,194,021, respectively, for loans he provided to the Company, unpaid salary
and unpaid business expenses. During the first three months of fiscal 2015, the Company settled $100,000 in outstanding payables
to the chief executive officer of by issuing 10,000,000 shares each of the Company’s Series F and G preferred stock and 10
shares of the Company’s Series E stock.
15
Note 14 – Fair Value
The Fair Value Measurements Topic of the FASB
Accounting Standards Codification establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to
measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets
or liabilities (Level 1 measurements) and the lowest priority to measurements involving significant unobservable inputs (Level
3 measurements). The three levels of the fair value hierarchy are as follows:
| · | Level 1: inputs are quoted prices (unadjusted) in active
markets for identical assets or liabilities that the company has the ability to access at the measurement date. |
| · | Level 2: inputs are inputs other than quoted prices
included within Level 1 that are observable for the asset or liability, either directly or indirectly. |
| · | Level 3: inputs are unobservable inputs for
the asset or liability. |
Under the Fair Value Measurements Topic of
the FASB Accounting Standards Codification, we base fair value on the price that would be received to sell an asset or paid to
transfer a liability in an orderly transaction between market participants at the measurement date. It is our policy to maximize
the use of observable inputs and minimize the use of unobservable inputs when developing fair value measurements, in accordance
with the fair value hierarchy. Fair value measurements for assets and liabilities where there exists limited or no observable market
data and, therefore, are based primarily upon management’s own estimates, are often calculated based on current pricing policy,
the economic and competitive environment, the characteristics of the asset or liability and other such factors. Therefore, the
results cannot be determined with precision and may not be realized in an actual sale or immediate settlement of the asset or liability.
Additionally, there may be inherent weaknesses in any calculation technique, and changes in the underlying assumptions used, including
discount rates and estimates of future cash flows that could significantly affect the results of current or future value.
Valuation Hierarchy
The table below presents the amounts of
assets and liabilities measured at fair value on a recurring basis as of February 28, 2015 and November 30, 2014:
The fair value of restricted securities are
measured with quoted prices in active markets. The fair value of the derivatives that are traded in less active over-the-counter
markets are generally measured using pricing models with non-observable inputs. These measurements are classified as
Level 3 within the fair value of hierarchy.
| | |
Total | |
(Level 1) | |
(Level 2) | |
(Level 3) |
| | |
| |
| |
| |
|
| February 28, 2015 | |
| |
| |
| |
|
| | |
| |
| |
| |
|
| Restricted securities | |
$ | 216,000 | | |
$ | 216,000 | | |
| — | | |
| — | |
| Derivative liability | |
$ | 2,770,117 | | |
| — | | |
| — | | |
$ | 2,770,117 | |
| | |
| | | |
| | | |
| | | |
| | |
| November 30, 2014 | |
| | | |
| | | |
| | | |
| | |
| | |
| | | |
| | | |
| | | |
| | |
| Restricted securities | |
$ | 1,040,000 | | |
$ | 1,040,000 | | |
| | | |
| | |
| Derivative liability | |
$ | 639,339 | | |
| — | | |
| — | | |
$ | 639,339 | |
The Company has no instruments with significant off balance sheet
risk.
16
In 2015, we estimated the fair value of
the derivative using the Black-Scholes valuation method with assumptions including: (1) term of 0 to 8.33 years; (2) a computed
volatility rate of 775% (3) a discount rate of 1% and (4) zero dividends. The valuation of this embedded derivative was recorded
with an offsetting gain/loss on derivative liability.
In 2014, we estimated the fair value of
the derivative using the Black-Scholes valuation method with assumptions including: (1) term of 0 to 9.33 years; (2) a computed
volatility rate of 339% (3) a discount rate of 1% and (4) zero dividends. The valuation of this embedded derivative was recorded
with an offsetting gain/loss on derivative liability.
Fluctuations in the conversion discount percentage
have the greatest effect on the value of the conversion liabilities valuations during each reporting period. As the conversion
discount percentage increases for each of the related conversion liabilities instruments, the change in the value of the conversion
liabilities increases, therefore increasing the liabilities on the Company's balance sheet. The higher the conversion discount
percentage, the higher the liability. A 10% change in the conversion discount percentage would result in more than a $110,000 change
in our Level 3 fair value.
Note 15 – Restatement
During 2015, the Company
determined that it should have recorded and valued tainted derivatives that had not previously been identified as derivatives.
As a result, the Company has restated its previously issued financial statements for the three-month period ended February 28,
2014. The restatement resulted in a decrease in beginning Retained Deficit at December 1, 2013 of $132,826, and a gain of $253,827
for the three-month period ended February 28, 2014, or a decrease of $31,650, as compared to a gain of $285,477 that had previously
been reported. The Company also reclassified deferred financing costs of $17,859 from selling, general and administrative costs,
to other expense.
The Company restated its consolidated financial
statements as of and for the three months ended February 28, 2014 as follows:
| | |
Three Months Ended February 28, 2014 |
| | |
| |
| |
| |
|
| | |
As Originally Reported | |
Adjustments | |
| |
As Restated |
| Selling, general and administrative costs | |
$ | 377,425 | | |
$ | (17,859 | ) | |
(1) | |
$ | 359,566 | |
| Other expense – deferred finance costs | |
| — | | |
| 17,859 | | |
(1) | |
| 17,829 | |
| (Gain) loss on value of derivative liabilities | |
| (285,477 | ) | |
| (31,650 | ) | |
(2) | |
| (253,827 | ) |
Adjustments to consolidated financial statements:
| (1) | To reclassify deferred finance expense to other expenses. |
| (2) | To record gain on the settlement of derivative liabilities. |
For the three-months ended February 28, 2014,
the restatement increased income from continuing operations by $17,859, decreased net income by $31,650, and had no effect on earnings
per share, which remained at $0.00.
Note 16 - Subsequent Events
Between March 1, 2015 and May 30, 2015
the Company issued 1,298,571,428 shares of common stock upon the conversion of debt and 1,000,000,000 shares in conjunction with
the acquisition of Canalytix. As of May 29, 2015, there were 4,702,630,209 shares of common stock outstanding. The
new shares upon conversion of debt were issued in separate transactions with investors, each of which exercised its right to convert
derivative securities issued by the Company in prior periods. The issuances were exempt from registration under Section
5 of the Securities Act by reason of Section 4(2) of said Act, as the investors were sophisticated, were given access to information
about the Company, and had taken the securities for investment. There were no underwriters.
17
On March 19, 2015 the Company filed
a certificate of amendment of its certificate of incorporation in which the Board of Directors designated the Series H Preferred
Stock, and corrected prior designations of preferred stock, from the Company’s previously authorized preferred stock with
a par value per share of $0.00001. The number of shares of Series H Preferred Stock was set at 800,000 shares. Shares of Series
H Preferred Stock have conversion rights into shares of Common Stock. The number of shares of Common Stock to which a holder of
Series H Preferred Stock shall be entitled upon a Conversion shall equal the product obtained by (a) multiplying the number of
fully-diluted Common Shares by four (4), then (b) multiplying the result by a fraction, the numerator of which will be the number
of shares of Series H Preferred Stock being converted and the denominator of which will be the number of authorized shares of Series
H Preferred Stock. Each share of Series H Preferred Stock shall entitle the holder thereof, on all matters submitted to a vote
of the stockholders of the Corporation, to that number of votes as shall be equal to the aggregate number of shares of Common Stock
into which such holder's shares of Series H Preferred Stock are convertible on the record date for the stockholder action. In the
event that the Corporation’s Board of Directors declares a dividend payable to holders of any class of stock, the holder
of each share of Series H Preferred Stock shall be entitled to receive a dividend equal in amount and kind to that payable to the
holder of the number of shares of the Company’s Common Stock into which that holder’s Series H Preferred Stock could
be converted on the record date for the dividend. Upon the liquidation, dissolution and winding up of the Corporation, the holders
of the Series H Preferred Stock shall be entitled to receive in cash out of the net assets of the Corporation, whether from capital
or from earnings available for distribution to its stockholders, before any amount shall be paid to the holders of common stock
or to the holders of any other class or series of equity stock, an amount equal to eighty percent (80%) of said net assets multiplied
by a fraction, the numerator of which shall be the number of outstanding shares of Series H Preferred Stock on the record date
for the distribution and the denominator of which shall be the number of authorized shares of Series H Preferred Stock.
On March 26, 2015, the Company executed
a securities purchase agreement (the “Agreement”) with Flux Carbon Corporation (“FCC”), pursuant to which
the Company acquired from FCC 90% of the issued and outstanding equity of Canalytix in consideration of the issuance by the Company
of 1,000,000,000 shares of common stock, par value $0.00001 (the “Common Stock”), and 100,000 shares of Series H preferred
stock, par value $0.00001 (the “Series H Preferred Stock”) of the Company. The sale of 1,000,000,000 shares of Common
Stock to the FCC gives the FCC a 21% ownership stake in the Common Stock of the Company, which now has 4,702,630,209 shares of
Common Stock outstanding. The sale of 100,000 shares of the Series H Preferred Stock gives the FCC an additional 10% of the voting
power and equity in the Company. The initial accounting for the business combination is incomplete until an independent auditor
can verify account balances. Canalytix was formed in 2013 to develop and market energy and resource efficiency technologies and
products, and is currently focused on doing so for indoor plant growth clients in the Colorado and other qualified markets. Canalytix
holds exclusive distribution rights to technology developed by Noveda Technologies, Inc., in hydroponic and other indoor plant
growth applications. Noveda is an innovative leader in real-time, web-based energy and water monitoring. Noveda's patented software
as a service (SaaS) solutions help reduce energy and water usage, optimize performance of renewable energy systems, and reduce
the carbon footprint for customers across commercial/retail, industrial, government, education, and utility sectors. Noveda also
offers real-time collaboration tools that leverage social media to educate and empower stakeholder communities and make the smart
grid a reality today.
On May 15, 2015, FFC signed a written agreement
with the Company to reduce the number of shares of common stock of the Company that it owns, initially 1,000,000,000 shares, by
an amount equal to the number of shares that the Company issues to its remaining secured debt holders. After conversion notices
are received by the Company from any secured debt holder with an outstanding balance as of May 15, 2015, and the Company issues
shares of common stock to retire the debt, the Company shall present evidence of the share issuance to FCC, and FCC shall return
the same number of shares to the Company’s treasury.
On May 11, 2015 the Company signed a securities
purchase agreement with Flux Carbon Starter Fund LLC (“Flux”) for the sale of a convertible promissory note (the “Note”)
in the principal amount of $140,000. The Note, which is due on December 31, 2015, bears interest at the rate of 6% per annum. All
principal and accrued interest on the Note is convertible into shares of the Company's common stock at the election of Flux, at
a conversion price equal to $0.002 per share. If the Company desires to exercise its right to prepay any portion of the Note before
it matures or is converted into shares of the Company’s common stock, the Company may deliver a prepayment notice to Flux,
three days before a prepayment is made. The prepayment amount shall equal 130% multiplied by the amount of the outstanding balance
paid by the Company.
18
Item 2. Management’s
Discussion and Analysis of Financial Condition and Results of Operations.
This quarterly report on Form 10-Q and other
reports filed by the Company from time to time with the U.S. Securities and Exchange Commission (collectively, the “Filings”)
contain or may contain forward-looking statements and information that are based upon beliefs of, and information currently available
to, the Company’s management as well as estimates and assumptions made by Company’s management. Readers are cautioned
not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof.
When used in the Filings, the words “anticipate,” “believe,” “estimate,” “expect,”
“future,” “intend,” “plan,” or the negative of these terms and similar expressions as they
relate to the Company or the Company’s management identify forward-looking statements. Such statements reflect the current
view of the Company with respect to future events and are subject to risks, uncertainties, assumptions, and other factors. Should
one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may
differ significantly from those anticipated, believed, estimated, expected, intended, or planned.
Although the Company believes that the expectations
reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, levels of activity, performance,
or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not
intend to update any of the forward-looking statements to conform these statements to actual results.
Our financial statements are prepared in accordance
with accounting principles generally accepted in the United States (“GAAP”). These accounting principles require us
to make certain estimates, judgments and assumptions. We believe that the estimates, judgments and assumptions upon which we rely
are reasonable based upon information available to us at the time that these estimates, judgments and assumptions are made. These
estimates, judgments and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial
statements as well as the reported amounts of revenues and expenses during the periods presented. Our financial statements would
be affected to the extent there are material differences between these estimates and actual results. In many cases, the accounting
treatment of a particular transaction is specifically dictated by GAAP and does not require management’s judgment in its
application. There are also areas in which management’s judgment in selecting any available alternative would not produce
a materially different result. The following discussion should be read in conjunction with our consolidated financial statements
and notes thereto appearing elsewhere in this report.
Overview
We develop and deliver
cloud-based technologies to emerging markets. We have operated over the past 10 years as a provider of video and voice over Internet
Protocol, or VoIP, telephony services. The nature of our technology is cloud-based computing, and therefore our target
market is not limited to our physical presence in the United States. In particular, we have transformed our VoIP service
to a downloadable digital product, which coupled with a fully-automated back office, allows us to sell our voice, video and messaging
services instantly to a large variety of mobile devices around the world.
We built a cloud-based
VoIP business, and sold most of this business on September 30, 2014, to Vaxstar LLC, (“Vaxstar”) a company whose chief
executive officer was our former chief information officer and member of our board of directors until September 15, 2014. This
transaction allowed us to continue to own the technology that we had developed, while transferring the bulk of our fixed operating
costs to another entity. Vaxstar simultaneously sold the business to Valuesetters, Inc. (“Valuesetters”) and Valuesetters
signed a licensing agreement with us that allows us to operate as a cloud-based VoIP service provider on a variable cost basis.
A percentage of each sales dollar that we earn is used to pay Valuesetters for all our operating costs, including technical support,
billing, customer services and termination fees to carriers.
In March 2015, we completed
an acquisition of a cloud-based indoor agricultural company, Canalytix LLC (“Canalytix”). We are in the final stages
of negotiating to purchase additional companies that we believe will be complementary to the Canalytix acquisition, with a view
towards consolidating a meaningful asset base and presence in emerging agricultural markets, both in Denver and elsewhere.
19
Plan of Operation
Our objective is to provide
reliable, scalable and profitable worldwide cloud-based services with unmatched quality by utilizing our software technologies
to deliver innovative mobile offerings at competitive prices. We intend to bring the best possible cloud-based products
and services, at an affordable price, to businesses and residential consumers and enhance the ways in which these customers connect,
communicate and collaborate with each other on a worldwide basis. We want to be known for our high quality of service, robust features
and ability to deliver any new product to a business customer or a web store without delay.
Specific strategies to accomplish this objective
include:
Mobile VoIP –
Mobility has become central to our growth plan. Consequently, our IP technology includes a mobile content platform
that has the ability to deliver high-quality voice, messaging and video communication, across wireless data networks. We
are offering our mobile VoIP product, as a downloadable application, on several web sites, including the Google Play and iTunes
application stores. We primarily market it as a second line on a consumer’s mobile device, although customers
can also use an Internet tablet and our mobile VoIP as their only telephone line. We believe that as consumers adopt
mobile VoIP and transition away from the circuit-switched networks now in use, consumers will find that having a second and third
phone line on their mobile devices will be helpful to distinguish between business and personal calls. Also, a second
or third phone line becomes very useful to people who do not want to give out their permanent mobile phone number to someone they
have recently met. Our mobile VoIP application comes with its own voice mail account so the customer can have a second
phone line with a professional voice mail message or a personal voice mail greeting, depending on the preferences of the customer.
Canalytix – We
plan to develop and market energy and resource technologies and products, and we are currently focused on doing so for indoor plant
growth clients in the Colorado and other qualified markets. Canalytix holds exclusive distribution rights to technology developed
by Noveda Technologies, Inc., in hydroponic and other indoor plant growth applications. Noveda is an innovative leader in real-time,
web-based energy and water monitoring. Noveda’s patented software as a service (SaaS) solutions help reduce energy and water
usage, optimize performance of renewable energy systems, and reduce the carbon footprint for customers across commercial, retail,
industrial, government, education, and utility sectors. Noveda also offers real-time collaboration tools that leverage social media
to educate and empower stakeholder communities and make the smart grid a reality today.
Results of
Operations
For the Three
Months Ended February 28, 2015 Compared to the Three Months Ended February 28, 2014
Our revenue for the three-month period ended
February 28, 2015 decreased by $212,768, or 99.6%, to $894, as compared to $213,662 reported for the three-month period ended February
28, 2014. The decrease in revenues was due to the sale of most of our customers on September 30, 2014. We believe we are now in
a better position to rebuild our revenues because our operating losses have decreased.
For
the three-month period ended February 28, 2015, our gross profit amounted to $268, which was a decrease of $89,360 from the gross
profit of $89,628 reported in the three-month period ended February 28, 2014. The reduction in gross profit is attributable to
the sale of most of our customers in the fourth quarter of fiscal 2014.
Selling, general and administrative expenses
decreased by $292,248 or 81%, to $67,318 for the three-month period ended February 28, 2015 from $359,566 reported in the same
prior-year fiscal period. The decrease was primarily due to a reduction in personnel cost and other cost cutting associated with
the sale of most of our customers in the fourth quarter of fiscal 2014.
20
As a result of the above noted changes, our
loss from operations for the three-month period ended February 28, 2015 decreased by $202,888 to $67,050 from $269,938 reported
in the prior-year fiscal period. However, significant non-operating income and expenses also occurred, thus:
| · | Interest expense decreased by $162,084 to $356,767 for the three-month
period ended February 28, 2015 as compared to $518,851 for the prior-year fiscal period. The decrease in interest expense
is attributable to less debt outstanding and larger borrowings in the first quarter of fiscal 2014 in which debt discounts equaled
or exceeded the face value of new promissory notes, resulting in significant amounts of amortization of debt discount. |
| · | For the three-month period ended February 28, 2015, we reported a
gain on troubled debt restructuring of $527,469, as compared to no transactions reported in the three-month period ended February
28, 2014. In the first quarter of fiscal 2015 we negotiated two debt modification agreements and one debt assignment agreement
that produced a gain on troubled debt restructuring, whereas no such transactions occurred in the prior-year fiscal period. |
| · | For the three-month period ended February 28, 2014, we reported a
gain on the sale of a subsidiary of $640,180, as compared to $0 reported in the three-month period ended February 28, 2015. No
such gain occurred in the three-month period ended February 28, 2015. |
| · | For the three-month period ended February 28, 2015, we reported a
gain on the extinguishments settlement of liabilities of $115,953, as compared to a gain of $300,686 in the three-month period
ended February 28, 2014. Each instance of a liability extinguishment is contingent upon the terms we can negotiate for a particular
transaction. |
| · | For the three-month period ended February 28, 2015, we had a loss
from the change in the valuation of derivative liabilities of $2,169,741, as compared to a gain of $253,827 for the period three-month
period ended February 28, 2014. The loss in three-month period ended February 28, 2015 is due to the higher market value of embedded
derivatives in our debt instruments, at the end of the fiscal quarter, because of the rising price per share of our common stock
at the end of the fiscal quarter. The gain in fiscal 2014 is due to the lower market value of embedded derivatives in our debt
instruments, at the end of the fiscal quarter, in comparison with the market value when the debt originated. |
Our net result for the three-month period ended
February 28, 2015 was a net loss of $1,953,441 compared to net income of $388,045 reported in the prior-year fiscal period.
Liquidity and Capital Resources
At February 28, 2015, we had cash and cash
equivalents of $2,623 and negative working capital of $11,957,513.
Operating activities for the three months ended
February 28, 2015 used $24,209 of cash, consisting principally of a net loss of $1,953,441, offset by approximately $1,753,000
in non-cash income statement charges and approximately $176,000 in changes in operating assets and liabilities. Operating results
for the three months ended February 28, 2014 used $168,049 of cash, consisting principally of net income of $388,045 plus approximately
$241,000 in changes in operating assets and liabilities, offset by approximately $797,000 in non-cash income statement charges.
Net cash provided by financing activities aggregated
$25,000 and $162,132 for the three-month periods ended February 28, 2015 and 2014, respectively. In the three months ended February
28, 2015, cash provided by financing activities resulted from proceeds from short-term borrowings of $25,000. For the three months
ended February 28, 2014, cash provided by financing activities resulted from proceeds from short-term borrowing of $222,500, less
repayments of debt of $60,368.
21
For the three months ended February 28, 2015
and 2014, we had no capital expenditures. We do not expect to make equipment purchases in the remainder of fiscal 2015.
The accompanying financial statements have
been prepared in conformity with generally accepted accounting principles, which contemplate continuation of our company as a going
concern. However, we have sustained net losses from operations during the last several years, and we have very limited
liquidity. Our operating losses have been funded through the issuance of equity securities and borrowings. Management
anticipates that we will be dependent, for the near future, on our ability to obtain additional capital to fund our operating expenses
and anticipated growth. The report of our independent registered public accounting firm, included in our Form 10-K for the year
ended November 30, 2014 expresses doubt about our ability to continue as a going concern. Our operating losses have
been funded through the issuance of equity securities and borrowings.
Although we have improved our balance sheet
with transactions to settle our debt, we continue to have liabilities in excess of our assets. We are working to settle
our remaining liabilities and to raise cash to support our operating loss, and we continually consider a variety of possible sources. In
the current economic environment, the procurement of outside funding is extremely difficult and there can be no assurance that
such financing will be available, or, if available, that such financing will be at a price that will be acceptable to us. If
we are unable to generate sufficient revenues or raise additional capital, our operations will terminate.
Item 3. Quantitative and Qualitative Disclosures
about Market Risk.
We are a smaller reporting company as defined
by Rule 12b-2 of the Securities Exchange Act of 1934, as amended, and are not required to provide information under this item.
Item 4.
Controls and Procedures.
(a) Disclosure Controls and Procedures.
The Company’s management, with the participation
of the Company’s principal executive officer (“PEO”) / principal financial officer (“PFO”), evaluated
the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) promulgated
under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by
this report. Based on this evaluation, the PEO / PFO concluded that, as of the end of such period, the Company’s disclosure
controls and procedures were not effective to ensure that information that is required to be disclosed by the Company in the reports
it files or submits under the Exchange Act is (i) recorded, processed, summarized and reported, within the time periods specified
in the SEC’s rules and forms and (ii) accumulated and communicated to the Company’s management, including the PEO /
PFO, as appropriate, to allow timely decisions regarding required disclosure. The material weaknesses in our disclosure controls
and procedures consisted of:
| ● |
There is a lack of accounting personnel with the requisite knowledge of Generally Accepted Accounting Principles in the US (“GAAP”), telecom taxation requirements and the financial reporting requirements of the SEC; |
| ● |
There are insufficient written policies and procedures to insure the correct application of accounting and financial reporting with respect to the current requirements of GAAP and SEC disclosure requirements; and |
| ● |
There is a lack of segregation of duties, in that we only had one person performing all accounting-related duties. |
(b) Changes in Internal Control Over Financial
Reporting
There have not been any changes in our internal
control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during our most
recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control
over financial reporting.
22
PART II – OTHER INFORMATION
Item 1. Legal Proceedings.
We are currently not involved in any litigation
that we believe could have a material adverse effect on our financial condition or results of operations. There is no action, suit,
proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body
pending or, to the knowledge of the executive officers of our company or any of our subsidiaries, threatened against or affecting
our company, our common stock, any of our subsidiaries or of our companies or our subsidiaries’ officers or directors
in their capacities as such, in which an adverse decision could have a material adverse effect.
Item 1A. Risk Factors.
We are a smaller reporting company as defined
by Rule 12b-2 of the Securities Exchange Act of 1934, as amended, and are not required to provide information under this item.
Item 2. Unregistered Sales of Equity Securities
and Use of Proceeds.
None
Item 3. Defaults Upon Senior Securities.
Except for matters described in Note 9 and
Note 16 of the consolidated financial statements, there have been no defaults in the payment of principal, interest, sinking or
purchase fund installment, or any other material default, with respect to any indebtedness of the Company.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information.
None
Item 6. Exhibits.
| Exhibit No. |
|
Document |
| |
|
|
| 31 |
|
Rule 13a-14(a) Certification |
| |
|
|
| 32 |
|
Rule 13a-14(b) Certification |
| |
|
|
| 101.INS |
|
XBRL Instance |
| |
|
|
| 101.SCH |
|
XBRL Schema |
| |
|
|
| 101.CAL |
|
XBRL Calculation |
| |
|
|
| 101.DEF |
|
XBRL Definition |
| |
|
|
| 101.LAB |
|
XBRL Label |
| |
|
|
| 101.PRE |
|
XBRL Presentation |
23
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
| |
|
|
PERVASIP CORP. |
| |
|
|
|
|
|
|
| |
|
|
|
|
|
|
| Date: June 8, 2015 |
|
By: |
/s/ Paul H. Riss |
|
| |
|
|
|
Name: |
Paul H. Riss |
|
| |
|
|
|
Title: |
Chief Executive Officer
(Principal Executive Officer)
(Principal Financial and
Accounting Officer) |
|
24
CERTIFICATION OF PRINCIPAL EXECUTIVE
OFFICER AND
PRINCIPAL ACCOUNTING OFFICER PURSUANT
TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 302
OF
THE SARBANES-OXLEY ACT OF 2002
I, Paul H. Riss, certify that:
| 1. |
I have reviewed this quarterly report on Form 10-Q of Pervasip Corp.; |
| |
|
|
| 2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
| |
|
|
| 3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods present in this report; |
| |
|
|
| 4. |
I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a-15(f) and 15d-15(f)) for the registrant and have: |
| |
|
|
| |
a) |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
| |
|
|
| |
b) |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
| |
|
|
| |
c) |
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
| |
|
|
| |
d) |
Disclosed in this report any change in the registrant’s internal control over financing reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
| |
|
|
| 5. |
I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
| |
|
|
| |
a) |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
| |
|
|
| |
b) |
Any fraud, whether or not material, that involved management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
|
Date: June 8, 2015 |
By: |
/s/ Paul H. Riss |
|
| |
|
Paul H. Riss |
|
| |
|
Principal Executive Officer,
Principal Financial Officer
Pervasip Corp. |
|
| |
|
|
|
|
|
CERTIFICATION
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF
THE SARBANES-OXLEY ACT OF 2002
In connection with this Quarterly Report
of Pervasip Corp. (the “Company”), on Form 10-Q for the quarter ended February 28, 2015, as filed with the U.S.
Securities and Exchange Commission on the date hereof, I, Paul H. Riss, Principal Executive Officer and Principal Financial Officer
of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley
Act of 2002, that:
| (1) | Such Quarterly Report on Form 10-Q for the
quarter ended February 28, 2015, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act
of 1934; and |
| (2) | The information contained in such Quarterly
Report on Form 10-Q for the quarter ended February 28, 2015, fairly presents, in all material respects, the financial condition
and results of operations of the Company. |
| |
|
|
|
| Date: June 8, 2015 |
By: |
/s/ Paul H. Riss |
|
| |
|
Paul H. Riss |
|
| |
|
Principal Executive Officer,
Principal Financial Officer
Pervasip Corp. |
|
| |
|
|
|
Pervasip (PK) (USOTC:PVSP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pervasip (PK) (USOTC:PVSP)
Historical Stock Chart
From Apr 2023 to Apr 2024
